Medication-info.com Search Menu

Isosulfan Blue Package Insert

Status:
Prescription (Rx) Facts
Strength:
10 mg/mL
Active ingredient:

Prescribing information (package insert) - Isosulfan Blue

DESCRIPTION

Dear Medical Professional,

Per your order we have compounded Isosulfan Blue 1%. The characteristics of this compounded preparation are as follows:

CLINICAL PHARMACOLOGY

Isosulfan Blue has no known pharmacologic action. Following subcutaneous administration, Isosulfan blue 1% is selectively picked up by the lymphatic vessels. Thus, the lymphatic vessels are delineated by a bright blue color making them discernible from surrounding tissue. There is some evidence that 50% of the isosulfan blue, from aqueous solution, is weakly bound to serum protein (albumin). Since interstitial protein is presumed to be carried almost exclusively by lymphtics, and in view of evidence of binding of dyes to proteins, visualization may be due to protein binding phenomenon.

INDICATIONS AND USAGE

Isosulfan Blue 1% Injection delineates the lymphatic vessels following subcutaneous administration. It is an adjunct to lymphography (in primary and secondary lymphedema of the extremities; chyluria, chylous ascites or chylothorax; lymph node involvement by primary or secondary neoplasm; and lymph node response to therapeutic modalities) for visualization to the lymphatic system draining the region of injection

DOSAGE AND ADMINISTRATION

Isosulfan Blue 1% is to be administered subcutaneously, one-half (1/2) ml into three (3) interdigital spaces of each extremity per study. A maximum dose of 3 ml (30 mg) isosulfan blue is injected.

CONTRAINDICATIONS

Hypersensitivity to triphenylmethane or related compounds

PRECAUTIONS

After subcutaneous administration of Isosulfan blue 1%, competent personnel and emergency facilities should be available for at least 30-60 minutes, since severe delayed reactions have been known to occur with similar compounds.

The admixture of Isosulfan blue with local anesthetics (i.e. lidocaine) in the same syringe prior to administration resulted in an immediate precipitation of 4-9% of the drug complex. This technique is not recommended

ADVERSE REACTIONS

Isosulfan blue 1% has demonstrated a 1.5% incidence of adverse reactions. All the reactions were of an allergic type such as localized swelling at the site of administration and mild pruritis of hands, abdomen and neck have been reported within several minutes following administration of the drug.

Storage and Handling

Store at room temperature

About this document

Source: FDA drug labeling via NLM DailyMed · View the label on DailyMed

Found a mistake? Write to us via the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Drug information for Isosulfan Blue

Rx or OTC
Prescription (Rx)?
  • This drug is available only with a prescription from a licensed healthcare provider.
  • Rx
Active ingredient Isosulfan blue 10 mg/mL
Dosage form Solution
Route Subcutaneous
Marketing status not in the current FDA NDC Directory
Company (applicant) AnazaoHealth Corporation
FDA approval UNAPPROVED DRUG OTHERUnapproved drug
Manufacturers 1 labelers list this drug on DailyMed
Packages (NDC)
Package
10 mg/mL – 5 ml in 1 vial NDC 51808-206-01

Source: FDA drug labeling via NLM DailyMed, data as of October 31, 2026. FDA data (DailyMed, Orange Book, Drug Shortages, enforcement reports). Not a substitute for the advice of a doctor or pharmacist.